HPLC Column Screening for Favipiravir on Six Different 100 x 4.6 mm Columns

Abstract:

Six different HPLC columns were screened to highlight retention differences for Favipiravir, an antiviral medication approved for use in Japan to treat resistant cases of influenza, which is also being studied as a potential treatment for COVID-19.

Document Type:

Technical Notes

Industries:

Pharmaceutical/Biopharmaceutical

Techniques:

HPLC / UHPLC

Brands:

Kinetex Luna

PDF Link:

Click here